Why the study?
The increasing prevalence of AF in adults with congenital heart disease and their unique anatomic and physiological background raise significant questions regarding management and the elimination of AF burden.
This review summarizes the challenges, safety, and efficacy of atrial fibrillation ablation in adults with congenital heart disease, highlighting emerging techniques and future research areas.
May inform ablation planning in ACHD patients with AF; leaves open need for dedicated prospective trials.
The increasing prevalence of atrial fibrillation (AF) in adults with congenital heart disease raises significant questions regarding its management. The unique underlying anatomic and physiological background further adds to the difficulty in eliminating the AF burden in these patients. Herein, we provide an overview of the current knowledge on the pathophysiology and risk factors for AF in adult congenital heart disease, with a special focus on the existing challenges in AF ablation. Emerging imaging modalities and ablation techniques might have a role to play. Evidence regarding the safety and efficacy of AF ablation in adult congenital heart disease is summarized, especially for patients with an atrial septal defect, Ebstein anomaly of the tricuspid valve, tetralogy of Fallot, and Fontan circulation. Finally, any remaining gaps in knowledge and potential areas of future research are highlighted.
No takes yet. Share an insight, caveat, or question.
Baroutidou et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: